What criteria are used to determine eligibility for autism therapies? 

In the UK, eligibility for autism-related therapies is not based on simple “mild/moderate/severe” labels. Instead, decisions are usually made using a mix of diagnosis, observed need, functional impairment and risk, within frameworks such as NICE guidance for children and young people, NICE guidance for adults, the SEND Code of Practice and the Care Act 2014. In practice, local thresholds for CAMHS, adult mental health and autism services can be higher than these documents imply, which means many autistic people who meet diagnostic criteria still struggle to access support. 

Eligibility criteria for children and young people 

For under-19s, NICE CG170 recommends support for autistic children and young people across the full range of intellectual ability, focusing on: 

• Social-communication interventions where core autistic features affect everyday interaction 

• Behavioural and psychosocial interventions when there is behaviour that challenges 

• Evidence-based treatments (such as adapted CBT) for co-existing mental-health problems 

• Help to develop communication, daily-living skills and access to education and leisure 

The guideline does not set a fixed “severity threshold”. Instead, eligibility is driven by identified needs such as communication difficulties, behaviour that challenges, anxiety, or significant impact on daily life identified through multidisciplinary assessment. 

In education, the SEND Code of Practice (0–25) states that children qualify for SEN support if they have significantly greater difficulty in learning than peers, or a disability that hinders use of school facilities. Schools must use a “graduated approach” (assess–plan–do–review) and can involve specialists such as speech and language therapy, occupational therapy or educational psychology when difficulties persist. An education, Health and Social Care system plan is considered when a child may need support beyond what a mainstream school can typically provide, with therapy input based on educational and functional need rather than diagnosis alone. 

Eligibility criteria for adults 

For adults, NICE CG142 recommends autism-informed support for anyone whose autism or related difficulties are affecting daily life. This includes: 

• Life-skills programmes when activities of daily living (e.g. self-care, shopping, managing money) are difficult 

• Social-learning programmes when there are clear difficulties with social interaction 

• Supported-employment schemes for people who want to work but struggle to obtain or keep a job 

• Adapted psychological therapies (such as CBT) for co-existing mental-health conditions 

When choosing interventions, NICE advises clinicians to consider the nature and severity of autism, the extent of functional impairment, any behaviour that challenges, and co-existing mental and physical health conditions. The autism quality standard QS51 expects local services to provide diagnostic assessment, autism-informed psychosocial interventions, and coordination of care. 

Adults usually access support by speaking to their GP or the team that diagnosed them, who can refer to local autism services, NHS Talking Therapies for anxiety and depression, or community mental health teams. Talking Therapies’ services base eligibility on common mental-health problems; autism itself is not an exclusion, but people may be stepping up to secondary care if risk or complexity exceeds service criteria. 

Social-care and real-world barriers 

In England, eligibility for funded adult social care under the Care Act 2014 depends on needs arising from impairment (including autism), difficulty achieving specified outcomes (such as maintaining a habitable home, relationships, or work) and a significant impact on wellbeing. Scotland, Wales and Northern Ireland use similar “needs and outcomes” models rather than diagnosis alone. 

Research shows, however, that being “eligible on paper” does not always translate into practical access. A BMJ Open survey of autistic adults found high rate of barriers to healthcare, including difficulties with telephone booking, sensory overload in waiting rooms and not feeling understood which were associated with untreated health conditions and delayed care. Reviews of mental-health access also highlight restrictive thresholds (for example rejecting people as “too complex”), long waits, and limited autism knowledge in services, as shown in a 2023 qualitative study on clinician-reported barriers to autism-informed care. 

Takeaway 

In the UK, eligibility for autism therapies is based on need, functional impact and risk within national frameworks, not on labels of “mild” or “severe” autism alone. NICE, SEND and Care Act 2014 guidance all support access where autism significantly affects daily life, yet local thresholds, capacity and accessibility can limit what people actually receive. Understanding the criteria – and advocating for needs, not just diagnosis – can help autistic people and families navigate the system more confidently.